Your browser doesn't support javascript.
loading
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.
Li, Zhi; Tuong, Zewen K; Dean, Isaac; Willis, Claire; Gaspal, Fabrina; Fiancette, Rémi; Idris, Suaad; Kennedy, Bethany; Ferdinand, John R; Peñalver, Ana; Cabantous, Mia; Murtuza Baker, Syed; Fry, Jeremy W; Carlesso, Gianluca; Hammond, Scott A; Dovedi, Simon J; Hepworth, Matthew R; Clatworthy, Menna R; Withers, David R.
Afiliação
  • Li Z; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Tuong ZK; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Dean I; Cellular Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Willis C; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Gaspal F; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Fiancette R; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Idris S; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Kennedy B; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Ferdinand JR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Peñalver A; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Cabantous M; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Murtuza Baker S; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Fry JW; Division of Informatics, Imaging & Data Science, Faculty of Biology, Medicine and Health, the University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Carlesso G; ProImmune Ltd., The Magdalen Centre, Oxford Science Park, Oxford, UK.
  • Hammond SA; Early Oncology R&D, AstraZeneca, Gaithersburg, MD.
  • Dovedi SJ; Early Oncology R&D, AstraZeneca, Gaithersburg, MD.
  • Hepworth MR; Early Oncology R&D, AstraZeneca, Cambridge, UK.
  • Clatworthy MR; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, the University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Withers DR; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
J Exp Med ; 219(6)2022 06 06.
Article em En | MEDLINE | ID: mdl-35472220
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Limite: Humans Idioma: En Revista: J Exp Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Limite: Humans Idioma: En Revista: J Exp Med Ano de publicação: 2022 Tipo de documento: Article